iugr and sga

30
DR Laxman Singh Charan Neonatal division Department of Pediatrics Safdarjang Hospital

Upload: laxman-charan

Post on 06-Nov-2014

1.057 views

Category:

Health & Medicine


4 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Iugr and sga

DR Laxman Singh Charan Neonatal division Department of Pediatrics Safdarjang Hospital

Page 2: Iugr and sga

Definitions

IUGR: Failure of normal fetal growth caused by multiple adverse effects on the fetus.

SGA: Infant with wt < 10% ile for GA, or > 2 SDs below mean for GA.

Page 3: Iugr and sga

Easiest way to think about these terms are

IUGR: is a term used by Obstetricians to describe a pattern of growth over a period of time.

SGA: is a term used by Pediatrician to describe a single point on a growth curve.

Page 4: Iugr and sga

IncidenceIn india.3 - 10 % of all pregnancies.20 % of stillborns are growth retarded.30 % of infants with SIDS were IUGR.1/3 of infants with BW < 2800 grams are growth

retarded and not premature.9 - 27 % have anatomic and/or genetic abnormalities.Perinatal mortality is 8 - 10 times higher for these

fetuses.

Page 5: Iugr and sga

Types of IUGRSymmetric IUGR: weight,length and head

circumference are all below the 10th percentile. (33 % of IUGR Infants)

Asymmetric IUGR: weight is below the 10 th percentile and head circumference and length are preserved. (55 % of IUGR)

Combined type IUGR: Infant may have skeletal shortening, some reduction of soft tissue mass.(12% of IUGR)

Page 6: Iugr and sga

Ponderal IndexWay of characterizing the relationship of height to

mass for an individual.

PI = 100 x

Typical values are 2.0 to 2.5PI is normal in symmetric IUGR.PI is low in asymmetric IUGR.

Mass (gm) Height (cm)3

Page 7: Iugr and sga

Normal Intrauterine Growth patternStage I (Hyperplasia)

- 4 to 20 weeks

- Rapid mitosis

- Increase of DNA contentStage II (Hyperplasia & Hypertrophy)

- 20 to 28 weeks

- Declining mitosis.

- Increase in cell size.

Page 8: Iugr and sga

Normal Intrauterine Growth patternStage III ( Hypertrophy) - 28 to 40 weeks - Rapid increase in cell size. - Rapid accumulation of fat, muscle and

connective tissue.95% of fetal weight gain occurs during last 20 weeks of

gestations.

Page 9: Iugr and sga

EtiologyGrowth inhibition in stage I: - Undersized fetus with fewer cells. - Normal cell size.

Result in symmetric IUGR.Associated conditions:

- Genetic - Congenital anomalies - Intrauterine infections - Substance abuse - Cigarette smoking - Therapeutic irradiation

Page 10: Iugr and sga

EtiologyGrowth Inhibition in Stage II/III

-Decrease in cell size and fetal weight

- Less effect on total cell numeric, fetal length, head circumferance.

Result in asymmetric IUGR.

Associated Conditions:

- Uteroplacental insufficiency.• Combination above associated mixed type IUGR.

Page 11: Iugr and sga

Pathophysiology(1) Fetal factors:Genetic Factors:

- Race, ethnicity, nationality- sex ( male weight 150 -200 gm more than female )- parity ( primiparous, weight less than

subsequent siblings) -genetic disorders ( Achondroplasia,

Russell-silver syndrome.)Chromosomal anomalies:

- Chromosomal deletions - trisomies 13,18 & 21

Page 12: Iugr and sga

PathophysiologyCongenital malformations:

Anencephaly, GI atresia, potter’s syndrome, and pancreatic agenesis.Fetal Cardiovascular anomaliesCongenital Infections:

mainly TORCH infections.Inborn error of metabolism:

- Transient neonatal diabetes- Galactosemia - PKU

Page 13: Iugr and sga

Pathophysiology(2) Maternal Factors:Decrease Uteroplacental blood flow:

- Pre eclampsia / eclampsia- Chronic renovascular disease- Chronic hypertension

Maternal malnutritionMultiple pregnancyDrugs

- Cigarettes, alcohol, heroin, cocaine- Teratogens, antimetabolites and

therapeuticagents such as trimethadione, warfarin, phenytoin

Page 14: Iugr and sga

PathophysiologyMaternal hypoxemia

- Hemoglobinopathies - High altitudes

• Others- Short stature- Younger or older age (<15 and >45)- Low socioeconomic class- Primiparity- Grand multiparity- Low pregnancy weight- Previous h/o preterm IUGR baby

- Chronic illness ( DM, renal failure, cyanotic heart- disease etc.)

Page 15: Iugr and sga

Pathophysiology(3) Placental Factors:Placental insufficiency (most importent in 3rd

trimester)Anatomic problems:

Multiple infarctsAberrant cord insertionsUmbilical vascular thrombosis & hemangiomasPremature placental separationSmall Placenta

Page 16: Iugr and sga

Postnatal AssessmentGrowth parameters- weight, height, HCAssess GA-with Ballard score.Growth chart -Plotted growth parameters in growth chart.

Page 17: Iugr and sga
Page 18: Iugr and sga
Page 19: Iugr and sga

Physical appearance:

• Heads are disproportionately large for their trunks and extremities

• Facial appearance has been likened to that of a “wizened old man”.

• Long nails.• Scaphoid abdomen

Page 20: Iugr and sga

• Signs of recent wasting- - soft tissue wasting - diminished skin fold thickness - decrease breast tissue - reduced thigh circumference

• Signs of long term growth failure- - Widened skull sutures, large fontanelles - shortened crown – heel length - delayed development of epiphyses

• Comparison to premature infants,IUGR has brain and heart larger in proportion to the body weight, in contrast the liver, spleen, adrenals and thymus are smaller.

Page 21: Iugr and sga

ComplicationHypoxia

- Perinatal asphyxia- Persistent pulmonary hypertension- meconium aspiration

Thermoregulation- Hypothermia due to diminished subcutaneous fat and elevated surface/volume ratio.

Page 22: Iugr and sga

ComplicationsMetabolic

- Hypoglycemia

- result from inadequate glycogen stores.

- diminished gluconeogenesis.

- increased BMR- Hypocalcemia

- due to high serum glucagon level, which stimulate calcitonin excretion.

Page 23: Iugr and sga

ComplicationsHematologic

- Hyperviscosity and polycythemia due to increase erythropoietin level secondary to hypoxia

Immunologic- IUGR have increased protein catabolism and decreased in protein, prealbumin and immunoglobulins, which decreased humoral and cellular immunity.

Page 24: Iugr and sga

ManagementAntenatal diagnosis and management is the key to proper

management of IUGRDelivery and Resuscitation

- appropriate timing of delivery- skilled resuscitation should be available- prevention of heat loss

Hypoglycemia

- close monitoring of blood glucose- early treatment ( IV dextrose,early feeding)

Page 25: Iugr and sga

ManagementHematological Disorder

- Hematocrit to detect polycythemia- CBC with differential to rule out leukopenia or thrombocytopenia

Congenital infection- Infant should be examined for signs of congenital infection (eg.rash, microcephaly hepatosplenomegaly, lymphadenopathy, cardiac anomalies etc….)- TORCH titer screening- Examination of urine, nasopharynx- Head CT to rule out calcification

Page 26: Iugr and sga

ManagementGenetic anomalies

- screening as indicated by physical exam- chromosomal analysis (infant with

dysmorphic features)Others

- serum calcium to r/o hypocalcemia- fractionated bilirubin secondary to polycythmia. congenital infection- urine,meconium for substance abuse

Page 27: Iugr and sga

ManagementEarly feeding and caloric intake should be 100-120

kcal/kg/dDevelopmental and growth f/u in all IUGR infants

Page 28: Iugr and sga

OutcomeSymmetric vs. Asymmetric IUGR

- symmetric has poor outcome compare to asymmetric

Preterm IUGR has high incidence of abnormalitiesIUGR with chromosomal disease has 100% incidence

of handicapCongenital infection has poor outcome - handicap

rate > 50%IUGR has higher rate of learning disability.

Page 29: Iugr and sga

FOLLOW-UPIUGR babies are risk for poor growth and neuro-

developmental outcome.Routinely follow IUGR babies with birth weight below 3rd

centile and those with birth weight 3-10th centile if they develop significant morbidities (e.g. hypoglycemia, polycythemia,birth asphyxia) during hospital stay.

Page 30: Iugr and sga